valsartan has been researched along with Alzheimer Disease in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Allam, EA; Elsharkawy, AM; Hammadi, SH; Hassan, MA; Shams, SS | 1 |
| Kitai, T; Krittanawong, C | 1 |
| Normile, D | 1 |
| Cohen-Solal, A; Hugon, J; Launay, JM; Mebazaa, A; Paquet, C; Vodovar, N | 1 |
| DeKosky, ST; Feldman, AM; Haller, JA | 1 |
| Brozena, S; Jessup, M; Owens, AT | 1 |
| Bartholomew, S; Chen, L; Ho, L; Humala, N; Pasinetti, GM; Qian, X; Rosendorff, C; Seror, I; Wang, J; Zhao, W; Zhao, Z | 1 |
2 review(s) available for valsartan and Alzheimer Disease
| Article | Year |
|---|---|
Pharmacogenomics of angiotensin receptor/neprilysin inhibitor and its long-term side effects.
Topics: Alzheimer Disease; Aminobutyrates; Angiotensin II Type 1 Receptor Blockers; Biphenyl Compounds; Drug Combinations; Heart Failure; Humans; Neprilysin; Pharmacogenetics; Randomized Controlled Trials as Topic; Tetrazoles; Valsartan | 2017 |
Neprilysin Inhibitors: Emerging Therapy for Heart Failure.
Topics: Alzheimer Disease; Aminobutyrates; Angioedema; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Drug Combinations; Heart Failure; Humans; Neprilysin; Patient Selection; Pyridines; Stroke Volume; Tetrazoles; Thiazepines; Valsartan | 2017 |
5 other study(ies) available for valsartan and Alzheimer Disease
| Article | Year |
|---|---|
Effect of sacubitril/valsartan on cognitive impairment in colchicine-induced Alzheimer's model in rats.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Cognitive Dysfunction; Colchicine; Drug Combinations; Heart Failure; Male; Neurodegenerative Diseases; Rats; Rats, Wistar; Tetrazoles; Valsartan | 2023 |
Biomedicine. Faulty drug trials tarnish Japan's clinical research.
Topics: Alzheimer Disease; Antihypertensive Agents; Biomedical Research; Brain; Clinical Trials as Topic; Drug Evaluation; Drug Industry; Humans; Japan; Positron-Emission Tomography; Product Surveillance, Postmarketing; Scientific Misconduct; Tetrazoles; Valine; Valsartan | 2014 |
Neprilysin, cardiovascular, and Alzheimer's diseases: the therapeutic split?
Topics: Alzheimer Disease; Aminobutyrates; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blood-Brain Barrier; Cardiovascular Diseases; Clinical Trials as Topic; Drug Combinations; Humans; Neprilysin; Tetrazoles; Valsartan | 2015 |
Valsartan/Sacubitril for Heart Failure: Reconciling Disparities Between Preclinical and Clinical Investigations.
Topics: Alzheimer Disease; Aminobutyrates; Amyloid beta-Peptides; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Brain; Disease Models, Animal; Drug Combinations; Drug Evaluation, Preclinical; Haplorhini; Heart Failure; Humans; Mice; Neprilysin; Retinal Degeneration; Tetrazoles; Valsartan | 2016 |
Valsartan lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Antihypertensive Agents; Behavior, Animal; Brain; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Humans; Memory; Mice; Mice, Transgenic; Protein Structure, Quaternary; Random Allocation; Space Perception; Tetrazoles; Valine; Valsartan | 2007 |